Status:
COMPLETED
Managing Side Effects in Clinical Practice
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Functional Gastrointestinal Disorders
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a quality improvement health services study in the Division of Gastroenterology at Beth Israel Deaconess Medical Center (BIDMC).
Detailed Description
The purpose of this study is to evaluate patients' reported experiences with regularly prescribed medications. No medications are prescribed as part of this study. Rather, if a patient are prescribed ...
Eligibility Criteria
Inclusion
- Patient is seen in the Division of Gastroenterology at BIDMC
- Patient is prescribed a medication for the treatment of functional gastrointestinal disorders that has not previously been tried by the patient
Exclusion
- Patient is not seen in the Division of Gastroenterology at BIDMC
- Patient has previously taken the drug that is prescribed
Key Trial Info
Start Date :
May 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03475550
Start Date
May 22 2017
End Date
September 30 2020
Last Update
December 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215